ENN0403 / EnnovaBio - LARVOL DELTA

A Phase 2, Multicenter, Randomized, Parallel Study to Evaluate the Efficacy and Safety of Two Doses of ENN0403 in Subjects With Diabetic Macular Edema (DME) (ChiCTR) - P2 | N=60 | Recruiting | Sponsor: Tianjin Medical University Eye Hospital; Shanghai EnnovaBio Pharmaceuticals Co., Ltd

New P2 trial • Diabetic Macular Edema • Ophthalmology • AOC3

Efficacy and Safety of ENN0403 in Patients At High Risk for Acute Kidney Injury Following Elective Cardiac Surgery (clinicaltrials.gov) - P2 | N=200 | Recruiting | Sponsor: EnnovaBio | Not yet recruiting ➔ Recruiting

Enrollment open • Acute Kidney Injury • Cardiovascular • Nephrology • Renal Disease

A Phase 2 Study to Evaluate the Efficacy and Safety of ENN0403 in Subjects with DME (clinicaltrials.gov) - P2 | N=60 | Recruiting | Sponsor: EnnovaBio | Not yet recruiting ➔ Recruiting

Enrollment open • Diabetic Macular Edema • Ophthalmology